Premium
Factor IX gene mutations in haemophilia B: a New Zealand population‐based study
Author(s) -
WATER NEIL S.,
WILLIAMS RUTH,
BERRY ELIZABETH W.,
OCKELFORD PAUL A.,
BROWETT PETER J.
Publication year - 1996
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/j.1365-2516.1996.tb00005.x
Subject(s) - haemophilia b , haemophilia , factor ix , haemophilia a , genetics , medicine , gene , allele , mutation , population , biology , environmental health
Summary. Haemophilia B (Christmas disease) is an X‐linked bleeding disorder resulting from an inherited deficiency of coagulation factor IX activity. Due to the heterogeneity of mutations within the factor IX gene there is a marked clinical variability in disease severity. By applying techniques of mutational analysis and direct sequencing of PCR products it is now potentially possible to determine the pathogenic gene defect in entire haemophilia B populations. We report here characterization of the factor IX gene defect in all the haemophilia B patients in New Zealand as part of a nationwide approach towards providing efficient and cost‐effective haemophilia B genetic counselling services for these families. Twenty‐six different mutations were identified in 32 unrelated haemophilia B families. Three defects at nucleotide positions +8,6659 and 17696 are novel mutations which have not been reported by other laboratories. A PCR‐based diagnostic screening test for direct mutational analysis could be performed in most cases; 17 of the 26 mutations altered a restriction enzyme recognition sequence and, with the exception of the total gene deletion, base changes not affecting a restriction enzyme site could be detected by allele‐specific PCR.